Skip to main content

Past Event
30 September - 1 October 2014


  • Lisa M. Ferri
    T +1 212 506 2340

ACI’s Paragraph IV Disputes Master Symposium

Why you should attend

This symposium – a companion to ACI’s Paragraph IV Disputes conference – is an advanced forum where leading Hatch-Waxman litigators representing both brand name and generic pharmaceutical companies will exchange ideas and engage in in-depth audience discussions addressing the complexities, conundrums and challenges which comprise today’s Paragraph IV litigation.

On this, the 30th anniversary of the Hatch-Waxman Act, this conference will delve into the evolution of the legal and regulatory intricacies and entanglements which have reshaped ANDA litigation. Factors from new PTO procedures instituted under patent reform to new settlement conundrums under Actavis, and a whole new cadre of Supreme Court patent decisions impacting critical Paragraph IV components such as claim construction, personal jurisdiction, 101 patent eligibility, and extraordinary circumstance are drastically changing the rules of the pharmaceutical patent endgame. This symposium will provide authoritative discussions on all these critical matters and offer valuable insights on how to meet these new challenges head-on.

Mayer Brown partner Lisa Ferri will be presenting on Tax Ethical Considerations for Paragraph IV Matters Before the PTO and District Courts: Looking Beyond Inequitable Conduct.

For more information or to register, please click on the button below.

The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.